文献速递神经创伤神经重症

创伤性蛛网膜下腔出血的分诊模式:是否有必要转诊至三级医疗中心?

Triage Patterns of Traumatic Subarachnoid Hemorrhage: Is Referral to a Tertiary Care Center Necessary?
PubMed 文献 · World Neurosurg · 2017-01-24

本回顾性分析纳入2010年1月至2014年12月转诊的67例孤立性创伤性蛛网膜下腔出血(iTSAH)患者,评估神经外科干预、影像学与临床进展及费用等结局。无患者需要神经外科干预,仅1例同时使用氯吡格雷与华法林者出现神经功能恶化伴影像学进展。作者认为,轻度颅脑损伤的iTSAH患者转诊至三级医疗中心通常并无必要,且可能增加费用。

要点

  • 67例iTSAH患者中无一人需要神经外科干预,仅1例出现神经功能恶化伴影像学进展。
  • 82.1%的患者格拉斯哥昏迷评分为15分,55.2%使用抗血小板或抗凝药物。
  • 作者认为,无其他损伤的iTSAH患者转诊至三级医疗中心通常并无必要,且可能增加费用。

核心结论

  • 在轻度创伤性脑损伤的iTSAH患者中,无论是否使用抗血小板/抗凝药物,因iTSAH扩大导致神经功能恶化的发生率均低。
  • 作者认为,转诊至三级医疗中心通常并无必要,且对无其他损伤的iTSAH患者可能费用高昂。

研究设计与样本

  • 回顾性分析,纳入2010年1月至2014年12月转诊且符合纳入标准的67例患者。
  • 主要结局为神经外科干预、影像学进展与临床进展;次要结局包括任何手术干预、住院时间、标准化住院费用、出院去向及30天死亡率。

主要发现

  • 队列平均年龄67.7±16.4岁,82.1%的患者格拉斯哥昏迷评分为15分。
  • 10例(14.9%)使用华法林,55.2%使用抗血小板或抗凝药物。
  • 无患者需要神经外科干预;1例同时使用氯吡格雷(Plavix)与华法林的患者出现神经功能恶化伴影像学进展。
  • 年龄较大似乎与影像学进展相关(P = 0.05);痴呆(P = 0.05)及华法林使用(P = 0.06)与临床进展相关。
  • 多因素分析显示,无其他损伤患者的费用与华法林使用(P = 0.0002)、损伤严重度评分(P = 0.01)及初始格拉斯哥昏迷评分(P = 0.0003)相关。

临床怎么用

  • 作者认为,对无其他损伤的iTSAH患者,转诊至三级医疗中心通常并无必要,且可能增加费用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Isolated traumatic subarachnoid hemorrhage (iTSAH) in mild head injuries has more evidence that triage to a tertiary care facility, intensive care unit admission, and repeat imaging is not warranted. Certain factors were identified that predict radiographic and clinical progression in hopes of preventing avoidable cost, which occur with transfer and subsequent management. METHODS: A retrospective analysis identified 67 patients transferred between January 2010 and December 2014 who met inclusion criteria. Primary outcomes assessing neurosurgical intervention, radiographic, and clinical progression were documented. Secondary outcomes included any operative intervention, length of stay, standardized hospital costs, disposition at discharge, and 30-day mortality. RESULTS: The mean age of the cohort was 67.7 ± 16.4 years, with most patients (82.1%) having a Glasgow coma score of 15. Warfarin was used in 10 patients (14.9%), although 55.2% were on an antiplatelet or anticoagulation agent. No patient required neurosurgical intervention. One patient, on clopidogrel (Plavix) and warfarin, neurologically declined with radiographic progression. Older age seem to correlate with radiographic progression (P = 0.05). Dementia (P = 0.05) as well as warfarin use (P = 0.06) correlated with clinical progression. Cost in patients without other injuries was associated with warfarin use (P = 0.0002), injury severity scores (P = 0.01), and initial Glasgow coma score (P = 0.0003) on multivariate analysis. CONCLUSIONS: In this series of patients with mild traumatic brain injury, the rate of neurological deterioration due to expansion of iTSAH in patients is low, regardless of the use of antiplatelets/anticoagulants. Triage to a tertiary care facility generally is not warranted and can prove costly to patients with iTSAH without other injures.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gates M, Mallory G, Planchard R, et al. Triage Patterns of Traumatic Subarachnoid Hemorrhage: Is Referral to a Tertiary Care Center Necessary? World Neurosurg. 2017. PMID: 28130166. doi:10.1016/j.wneu.2017.01.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。